SecBot SecBot

BIO

BIO-RAD LABORATORIES, INC.
NYSE· Laboratory Analytical Instruments· Inc. DE· CIK 0000012208 Industrials & Manufacturing
$360.26 −6.10 (−1.67%)
Nov 16 4:00 PM ET · prev $366.36
Market cap
$9.8B
Mid cap
Consensus
Buy
50% Buy or better · 10 analysts
Median target
$350.00
−3% · range $280.00–440.00
1 year
+18.5%
from $304.06 · Nov 17
30 days
+2.1%
from $352.82
52-week range
$241.71–390.34
−8% from high · low May 12
Avg volume 20D
253.8K
shares / day
Short interest
1.16M
≈4.3% of shares · +5.4%
Days to cover
5.1
at average volume
Insider net
−$1.2M
0 buyers · 3 sellers · since Sep 4
New fund stakes
1
Q3 2026 13F · 3 exits
Filing reports
9
analyzed by SecBot
SecBot read BEARISH 8 reports · 90 days
Balance 2 bearish · 0 bullish · 1 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 5/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders sold $1.2M.

  • InstitutionsMIXED

    Q3 2026: 30 added (1 new), 28 trimmed or exited.

  • AnalystsBULLISH

    5 of 10 rate it Buy or better. Median target $350.00 (−3%).

  • Short sellersSTEADY

    Short interest +5.4% to 1.16M shares. 5.1 days to cover, ≈4.3% of shares.

  • TrendRANGE

    3% below its 50-day average.

Who's buying

13F· Q3 2026
1
new positions
3
exits
FundMoveSharesValue
Capital Research Global InvestorsADD596,244$225.2M
Neuberger Berman Group LLCDOUBLED396,150$149.6M
MORGAN STANLEYADD307,206$116.0M
FMR LLCDOUBLED220,119$83.1M
VICTORY CAPITAL MANAGEMENT INCADD188,088$71.0M
Assenagon Asset Management S.A.TRIM147,506$55.7M
MARSHALL WACE, LLPDOUBLED67,994$25.7M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED66,578$25.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 50% rate it Buy or better
Strong Buy1Buy4Hold4Sell1Strong Sell0
12-month targets · 3 analysts

Price is inside the target range. Median implies −3%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 5, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 7, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 5, 2026Citigroup
MAINTAIN
MAINTAINNeutral
Aug 5, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 5, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight

Insider ledger

Form 4
$0
bought · 0 insiders
$1.2M
sold · 3 insiders
DateInsiderTypeValue
Nov 10, 2026
ENLOE COURTNEY C
EVP, General Counsel & Sec
Nov 10, 2026
SELL$348.3K
Nov 9, 2026
DiVincenzo Jonathan P.
President & COO
Nov 9, 2026
SELL$358.8K
Nov 9, 2026
BARRY JAMES
EVP, President, LSG
Nov 9, 2026
SELL$539.9K
Oct 24, 2026
DiVincenzo Jonathan P.
President & COO
Oct 24, 2026
EXERCISE1,869 sh
Oct 24, 2026
DiVincenzo Jonathan P.
President & COO
Oct 24, 2026
TAX W/H$351.8K
Oct 20, 2026
EVRAN SEDAT
EVP, Global Supply Chain
Oct 20, 2026
TAX W/H$172.6K
Oct 20, 2026
EVRAN SEDAT
EVP, Global Supply Chain
Oct 20, 2026
EXERCISE1,044 sh
Sep 6, 2026
BARRY JAMES
EVP, President, LSG
Sep 6, 2026
EXERCISE1,056 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

8 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
1,156,915
shares short
+5.4%
vs prior settlement
5.1
days to cover
≈4.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Two senior executives at Bio-Rad (President & COO and EVP/President of Life Science Group) sold a combined $899K in…
CLUSTER · Impact 3/10
Nov 10, 2026 SEC
Courtney Enloe, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 902 shares of common…
144 · Impact 2/10
Nov 10, 2026 Insider
ENLOE COURTNEY C sold 902 shares
EVP, General Counsel & Sec @ $386.17 ($348.3K)
Nov 9, 2026 SEC
Jonathan P. DiVincenzo, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 919 shares of…
144 · Impact 2/10
Nov 9, 2026 Insider
DiVincenzo Jonathan P. sold 919 shares
President & COO @ $390.47 ($358.8K)
Nov 9, 2026 Insider
BARRY JAMES sold 1,400 shares
EVP, President, LSG @ $385.63 ($539.9K)
Nov 4, 2026 Earnings result
BIO Q3 2026 Earnings: EPS $2.65 (+17.9% vs est)
Sep 30, 2026 Inst.
Capital Research Global Investors · ADD
596,244 shares ($225.2M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

9 filings · 0 bullish · 2 bearish · 2 mixed · 5 neutral
All BIO filing & press-release reports (9)